| Alogliptin | 🇺🇸United States | 12.5MG BASE, 25MG BASE, 6.25MG … | tablet | Tentative approval | MSN Labs PVT LTD |
| benzoato de alogliptina | 🇧🇷Brazil | | | Authorised | Eurofarma Laboratorios S.A. |
| benzoato de alogliptina | 🇧🇷Brazil | | | Authorised | Brainfarma Indústria Química e Farmacêutica S.A |
| benzoato de alogliptina | 🇧🇷Brazil | | | Authorised | Althaia S.A. Industria Farmaceutica |
| Alogliptin; Metformin HydrochlorideCombination | 🇺🇸United States | 12.5MG BASE; 1GM, 12.5MG BASE; 500MG | tablet | Tentative approval | Torrent Pharms LTD |
| Alogliptin and Metformin HydrochlorideCombination | 🇺🇸United States | 12.5MG/1000MG, 12.5MG/500MG | tablet | Tentative approval | MSN Laboratories Private LTD |
| cloridrato de metformina + benzoato de alogliptinaCombination | 🇧🇷Brazil | | | Authorised | Brainfarma Indústria Química e Farmacêutica S.A |
| cloridrato de metformina + benzoato de alogliptinaCombination | 🇧🇷Brazil | | | Authorised | Makrofarma Quimica Farmaceutica Ltda |
| cloridrato de metformina + benzoato de alogliptinaCombination | 🇧🇷Brazil | | | Authorised | Sanusphar Pesquisa e Desenvovimento Ltda |
| benzoato de alogliptina + cloridrato de pioglitazonaCombination | 🇧🇷Brazil | | | Authorised | Makrofarma Quimica Farmaceutica Ltda |
| benzoato de alogliptina + cloridrato de pioglitazonaCombination | 🇧🇷Brazil | | | Authorised | Brainfarma Indústria Química e Farmacêutica S.A |
| benzoato de alogliptina + cloridrato de pioglitazonaCombination | 🇧🇷Brazil | | | Authorised | Sanusphar Pesquisa e Desenvovimento Ltda |
| KazanoCombination | 🇺🇸United States | 12.5MG BASE; 1GM, 12.5MG BASE; 500MG | tablet | Marketed | Takeda Pharms USA |
| Nesina | 🇺🇸United States | 12.5MG BASE, 25MG BASE, 6.25MG BASE | tablet | Marketed | Takeda Pharms USA |
| OseniCombination | 🇺🇸United States | 12.5MG BASE; 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 12.5MG BASE; 30MG BASE, 12.5MG BASE; 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet | Marketed | Takeda Pharms USA |
| benzoato de alogliptina | 🇧🇷Brazil | | | Cancelled | Makrofarma Quimica Farmaceutica Ltda |
| IncresyncCombination | 🇪🇺European Union | | | Authorised | Takeda Pharma A/S |
| Incresync 12,5 mg/30 mg comprimidos recubiertos con peliculaCombination | 🇪🇸Spain | 12,5 mg + 30 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| Incresync 25 mg/30 mg comprimidos recubiertos con peliculaCombination | 🇪🇸Spain | 25 mg + 30 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| VipdometCombination | 🇪🇺European Union | | | Authorised | Takeda Pharma A/S |
| Vipdomet 12,5 MG/1000 MG Comprimidos Recubiertos con PeliculaCombination | 🇪🇸Spain | 12,5 mg + 1000 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| Vipdomet 12,5 MG/1000 MG Comprimidos Recubiertos con PeliculaCombination | 🇪🇸Spain | 12,5 mg + 1000 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| Vipdomet 12,5 MG/1000 MG Comprimidos Recubiertos con PeliculaCombination | 🇪🇸Spain | 12,5 mg + 1000 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| Vipdomet 12,5 MG/850 MG Comprimidos Recubiertos con PeliculaCombination | 🇪🇸Spain | 12,5 mg + 850 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
| Vipdomet 12,5 MG/850 MG Comprimidos Recubiertos con PeliculaCombination | 🇪🇸Spain | 12,5 mg + 850 mg | comprimido recubierto con película | Marketed | Takeda Pharma A/S |
